Published on 9 Oct 2023 on Simply Wall St. via Yahoo Finance
Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold...
Key Insights
Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over the company's share priceThe top 6 shareholders own 53% of the company Recent sales by insiders
To get a sense of who is truly in control of Lyell Immunopharma, Inc. (NASDAQ:LYEL), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 49% to be precise, is institutions. In other words, the group stands to gain the most (or lose the most) from their investment into the company.